Friday 6 November 2026 Export GMED’s income statement to Excel — free account

Globus Medical, Inc.

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue: −0.69%
EPS: +19.3%
Free cash flow: +10.1%

Quarter to September 2026, against a year earlier

72.24 9.20 −11.30%

Follow GMED

Alert me

Market cap: $10.9B
P/E: 19.5×
Fwd P/E: 18.8×
Dividend yield: —
F-score: 9/9
Altman Z: 11.30
Beneish M: −2.31
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Globus Medical, Inc. (GMED) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Reportable Segment	2,939	100.00%
Gross margin		67.41%
Operating margin		16.33%
Pre-tax margin		20.59%

Revenue by product or service $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Musculoskeletal Solutions	2,798 95.20%	2,365 93.89%	1,448 92.34%	927 90.60%	877 91.51%	748 94.86%	738 94.02%	666 93.42%	625 98.28%	—	—	—	—	—	—	—
Enabling Technologies	141 4.80%	154 6.11%	120 7.66%	96 9.40%	81 8.49%	41 5.14%	47 5.98%	47 6.58%	11 1.72%	—	—	—	—	—	—	—
Innovative Fusion	—	—	—	—	—	—	—	—	—	288 50.99%	288 52.88%	271 57.10%	254 58.47%	239 61.85%	224 67.68%	216 74.80%
Disruptive Technology	—	—	—	—	—	—	—	—	—	276 49.01%	257 47.12%	204 42.90%	180 41.53%	147 38.15%	107 32.32%	73 25.20%
Revenue	2,939	2,519	1,568	1,023	958	789	785	713	636	564	545	474	434	386	331	288

Revenue by segment $m

Line	FY2025	FY2024	FY2023
Reportable Segment	2,939 100.00%	2,519 100.00%	1,568 100.00%
Revenue	2,939	2,519	1,568

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023
Reportable Segment	‡	‡	‡
Corporate and other	‡	‡	‡
Operating income	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
United States	2,368 80.56%	2,000 79.39%	1,280 81.59%	872 85.25%	820 85.54%	664 84.21%	648 82.47%	594 83.30%	530 83.32%	500 88.69%	498 91.45%	427 90.03%	397 91.29%	356 92.13%	311 93.83%	278 96.45%
International	571 19.44%	519 20.61%	289 18.41%	151 14.75%	139 14.46%	125 15.79%	138 17.53%	119 16.70%	106 16.68%	64 11.31%	47 8.55%	47 9.97%	38 8.71%	30 7.87%	20 6.17%	10 3.55%
Revenue	2,939	2,519	1,568	1,023	958	789	785	713	636	564	545	474	434	386	331	288

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.